Test Price
800 AED✅ Home Collection Available
NTRK1 Gene Rearrangement Assay (FISH) – Precision Oncology Test in Dubai
Executive Summary & Core Metrics
Executive Summary
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
Premium Logistics: Secure Medical Courier Solid Tissue Specimen Retrieval – temperature-controlled transport of archival FFPE blocks or slides. Home collection is not applicable due to the specimen type.
Clinical Guidance: Telephonic Post‑Test Clinical Guidance in result interpretation by DHA‑licensed specialists.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The NTRK1 Gene Rearrangement Assay (FISH) detects specific genomic rearrangements of the neurotrophic tyrosine receptor kinase 1 gene in solid tumors, directly guiding eligibility for targeted TRK inhibitor therapy. This 800 AED test uses fluorescence in‑situ hybridization on FFPE tissue blocks, delivering DHA‑licensed results within 4 working days.
| Feature | Our NTRK1 FISH Test | Closest Alternative (NGS Panel) |
|---|---|---|
| Methodology | Fluorescence In‑Situ Hybridization (FDA‑cleared probes) | Next‑Generation Sequencing (RNA or DNA) |
| Diagnostic Sensitivity | >99% for known partner fusions | ~98% (requires high tumour content) |
| Turnaround Time | 4 working days | 7–10 working days |
| Cost | 800 AED | 2,500–3,500 AED |
| Sample Requirement | FFPE block or 3 sections on coated slides | FFPE block (10–15 slides) or fresh tissue |
| Regulatory Clearance | DHA‑licensed, ISO 9001:2015 | Variable; may lack local accreditation |
Physician Insight & Safety Protocols
“As a DHA‑licensed specialist, I emphasize that a positive NTRK1 fusion result must be correlated with histopathology and clinical presentation before initiating TRK inhibitor therapy. This test is critical for identifying candidates for targeted treatment but should never be used as a standalone diagnostic tool. Always discuss results with your treating oncologist to ensure a comprehensive care plan.”
— Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology, DHA Registration ID: 61713011
Advisory: Medication and Treatment Considerations
Do not discontinue any prescribed medication without consulting your doctor. Test results must be interpreted alongside your current treatment regimen. Always inform your healthcare provider about all medications and supplements before proceeding.
Patient Safety Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Liquid cytology specimens (e.g., fine‑needle aspirates) are not acceptable; the assay requires adequate tumour tissue in a paraffin block. Patients who have recently completed chemotherapy should wait at least 2 weeks before biopsy to allow tissue recovery.
- Emergency Red Flags: If you experience sudden tumour site pain, active bleeding, or signs of infection (fever, redness) at the biopsy area, seek immediate medical attention.
For emergency assistance, contact your nearest DHA‑accredited hospital.
Patient FAQ & Clinical Guidance
1. What is the NTRK1 Gene Rearrangement Assay?
Snippet: The NTRK1 Gene Rearrangement Assay (FISH) detects specific DNA rearrangements in the NTRK1 gene within cancer cells, determining eligibility for targeted TRK inhibitor therapy.
This FISH‑based test visualizes gene fusions directly in tumour tissue, providing a fast and accurate yes/no answer regarding NTRK1 alteration status.
2. How should I prepare for the NTRK1 FISH test?
Snippet: No special preparation is required beyond providing a formalin‑fixed paraffin‑embedded tissue block or slides and the mandatory Genomics Clinical Information Requisition Form (Form 20).
Your surgeon or oncologist will arrange tissue submission; ensure the Form 20 is completed with all clinical details to avoid processing delays.
3. What do the results mean for my cancer treatment?
Snippet: A positive result indicates an NTRK1 gene rearrangement, which may qualify you for targeted TRK inhibitor therapy, while a negative result suggests standard treatment.
All results are interpreted by a DHA‑licensed surgical pathologist and radiologist along with your treating oncologist to integrate findings into your personalized care plan.
UAE Regulatory & Data Privacy Adherence
Regulatory and Privacy Compliance
This diagnostic service adheres strictly to the United Arab Emirates data protection and healthcare regulations:
- Data Security: Compliant with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL). All genomic and personal data are encrypted and stored within secured UAE servers.
- Health Information: Processes and transmits health data in accordance with Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Clinical Safety: Informed consent and medical liability are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Accreditation: Facility licensed by the Dubai Health Authority (DHA License No. 1143) and ISO 9001:2015 certified for quality management.
Clinical & Logistical Metadata
| Test Name | NTRK1 Gene Rearrangement Assay (FISH) |
| Price (AED) | 800 AED |
| Turnaround Time | 4 working days |
| Sample Type / Matrix | Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Block or Slides (Archival Tissue Specimen) |
| Methodology Used | Fluorescence In-Situ Hybridization (FISH) |
| ICD-10-CM Code | Z15.09 |
| LOINC Code | 92896-2 |
| DHA Facility License & Laboratory Address | DHA License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians